ANEW Medical Partners With Okinawa Research Center to Develop Longevity Drugs

MT Newswires Live
2024-06-27

ANEW Medical (WENA) said Thursday it has partnered with researchers at Japan's Okinawa Research Center for Longevity Science for the development of its Klotho gene therapy in reducing age-related diseases.

Okinawa is among a set of global "Blue Zones" with high numbers of people who live to high ages and remain in good health.

ANEW said preliminary data suggests that the alpha-Klotho version of the human Klotho gene and its secreted alpha-Klotho protein isoform may contribute to long lifespans and protection against diseases such as Alzheimer's Disease. The company is developing a portfolio of therapies targeting the gene.

Price: 3.4200, Change: -0.20, Percent Change: -5.52

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10